Family Control

Family Control

Pernod Ricard is a founder-family-controlled company. Société Paul Ricard, wholly owned by the Ricard family, holds 14.29% of the capital but 20.64% of the votes through France's double-voting rule, and has lifted its stake in every year of the downturn [1]. With Groupe Bruxelles Lambert alongside it, two long-term anchors hold roughly a third of the votes. This shapes two things a buyer of the stock inherits: who the dividend really answers to, and whether a takeover can ever happen.

Sources: shareholding at 30 June 2025, FY2025 URD Ch.9 [2]; board independence, FY2025 URD §2.1.2.1 [3].

Who owns it, and who runs it

The Group carries the founding family's name because the family still controls it. Société Paul Ricard — a holding company wholly owned by the Ricard family — held 36,042,689 shares at 30 June 2025, or 14.29% of the capital, and its four related vehicles (Le Garlaban and the three Delos Invest companies) are controlled by it under French law [4]. Because long-held registered shares carry double votes (see below), that 14.29% of capital converts into 20.64% of the votes — a 1.44-to-1 wedge between economic exposure and voting power [5].

The family also runs it. Alexandre Ricard, a grandson of founder Paul Ricard, has been the Group's combined Chairman and CEO since 11 February 2015 [6]. Two further family members sit on the board — César Giron, another grandson of the founder, and Patricia Ricard Giron — both as non-independent directors [7]. The second anchor is Groupe Bruxelles Lambert, the Belgian holding company, which has held its stake since 2017 — 6.82% of capital and 11.36% of the votes — and is represented on the board by Ian Gallienne [8]. Together the two hold 21.11% of the capital and 32.00% of the votes. The rest of the register is a wide institutional free float — MFS, BlackRock and Wellington each held between 3% and 5% at year-end, none of them a control bloc [9].

Source: FY2025 URD, breakdown of share capital and voting rights over the last three years [10].

The family's grip is tightening, not loosening. Through the very years the share price fell, Société Paul Ricard's holding rose from 14.07% of capital (20.41% of votes) at June 2023 to 14.21% (20.57%) at June 2024 to 14.29% (20.64%) at June 2025 [11]. Some of that drift comes mechanically — the Group cancels the shares it buys back, so a static family holding rises as a percentage of a shrinking count — but the share count held also rose each year, from 35.96m to 36.04m [12]. The people closest to the business added to it while the market sold.

The control machinery

France gives long-term owners tools that a common-stock reading of "14% of capital" misses, and Pernod Ricard uses all of them. Three matter.

Double voting rights. Any fully paid share registered in the same name for at least ten years carries two votes, a right the Group has run since 1986 [13]. It rewards exactly the behaviour the family and GBL exhibit — hold, in registered form, for a long time — and it is why their 21% of capital speaks with 32% of the voice. A short-term holder gets one vote; the anchors get two.

A 30% voting cap. No single shareholder may cast more than 30% of the votes at a meeting, whatever their holding [14]. This cuts both ways: it stops the family from ever holding an outright majority of votes on its own, but it is also a classic anti-takeover device — a hostile acquirer who bought a majority of the shares would still be capped at 30% of the votes.

Early-warning disclosure. The bylaws require any holder crossing 0.5% of capital to notify the Company, and again at every further 0.5% up to 4.5% — a granularity far tighter than the statutory thresholds, and one that makes silent stake-building visible early [15]. Sitting behind all of it, the Group's financing agreements carry change-of-control clauses that allow lenders to demand early repayment if control shifts [16]. Taken together, the structure means Pernod Ricard is effectively not acquirable against the family's wishes. That near-certainty works in both directions: it protects the business from a hostile bid and forecloses the premium one could deliver.

What it means for the case

The ownership structure is not a governance footnote; it bears directly on the dividend and on the Group's ability to be patient through the reset.

On the dividend. Cash and the Dividend showed the payout has drifted above reported free cash flow and is defended only on the company's "recurring" measure. Ownership tells you who is doing the defending, and why. Société Paul Ricard is a pure holding company; its principal asset is the Pernod Ricard stake, so the Group's dividend is the family vehicle's main source of income. At the €4.70 per share held flat since FY2023, the family's 36.04m shares collect roughly €169m of dividends a year [17]. A controlling owner that lives on the dividend is structurally disinclined to cut it — and the record fits: after a COVID trim to €2.66 in FY20, the dividend was rebuilt to €4.70 by FY23 and has been held there through two years of falling profit rather than reduced to match cash generation [18]. This is the company-specific reason the 7.4% yield has more support than a coverage ratio alone implies. It is support, not a guarantee: the policy is a payout ratio, not a floor, and a deep enough or long enough trough could still force a cut — but the controlling shareholder's incentives lean hard the other way.

Source: dividend history FY19–FY23, FY2023 URD [19]; €4.70 held for FY24–FY25, FY2025 URD [20].

On patience. A long-horizon, family-and-GBL controlled register lets management prioritise the things that only pay off over years — brand equity, and the aged Scotch and cognac that sit maturing on the balance sheet — over the quarterly earnings a widely-held peer must protect. A patient owner is an asset to a business working through a multi-year reset. It is the same feature that lets the Group hold the dividend and the aged-inventory strategy at the same time.

The counter. Entrenchment cuts both ways, and the same structure that supports the income case caps the upside. There will be no takeover premium and no activist lever: the 30% cap, double votes and change-of-control clauses foreclose the external pressure that forces value out of an unloved, cash-generative asset elsewhere. If the market is wrong about Pernod Ricard, the correction has to come from the business recovering, not from a bid — a depressed price can simply persist. Governance concentration adds to the caution. The combined Chairman-and-CEO role puts strategy and its oversight in one family member's hands; it is mitigated by a 58.3% independent board and a Lead Independent Director in post since 2019 [21], but it is the same combined authority under which the pro-cyclical, peak-of-cycle acquisitions flagged in Capital Allocation were made. The same structure that defends the dividend also bears responsibility for those timing mistakes.

The net read: for an income-oriented buyer, family control is a support — it aligns the largest voter with the payout and the long horizon the recovery thesis needs. For a buyer hoping the market's discount gets closed by an outside catalyst, it is a wall: any re-rating will have to come from the business recovering rather than from a bid.